You have successfully sign out
Loading...
Crescent Biopharma, Inc.
CBIO
Company Description
Crescent Biopharma, Inc., an oncology company, develops therapies for cancer patients. Its pipeline includes a PD-1 x VEGF bispecific antibody, as well as novel antibody-drug conjugates to treat solid tumors. The company is headquartered in Waltham, Massachusetts.
Â
NASDAQ
Unprofitable
Unprofitable
12.03USD
0.13Â ( 1.09%)
Pre-market 11.99$
-0.04 (-0.33%)Market Closed (as of Oct 02, 20:00 EDT)
Relative Strenght
15
Volume Buzz
-64%
Earning Acce
No
Dist 52w H.
81%
